PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
0.07%
Net income growth under 50% of CRWD's 17.27%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
5.46%
Less D&A growth vs. CRWD's 14.74%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
242.93%
Some yoy growth while CRWD is negative at -4230.97%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
4.77%
SBC growth well above CRWD's 6.89%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-52.05%
Both reduce yoy usage, with CRWD at -10.02%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-1574.21%
Both yoy AR lines negative, with CRWD at -416.93%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-65.23%
Negative yoy inventory while CRWD is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
411.35%
AP growth well above CRWD's 424.43%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
485.36%
Growth well above CRWD's 76.94%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
13722.86%
Well above CRWD's 15.59%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-2.98%
Negative yoy CFO while CRWD is 0.41%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-28.67%
Negative yoy CapEx while CRWD is 10.62%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
93.25%
Some acquisitions while CRWD is negative at -1529.93%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
43.61%
Less growth in investment purchases vs. CRWD's 94.12%, preserving near-term liquidity. David Dodd would confirm no strategic investment opportunities are lost.
-74.92%
We reduce yoy sales while CRWD is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
3.64%
We have some outflow growth while CRWD is negative at -305.56%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
39.84%
We have mild expansions while CRWD is negative at -109.37%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
100.00%
Debt repayment growth of 100.00% while CRWD is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
-3.35%
Negative yoy issuance while CRWD is 684.75%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
0.74%
Buyback growth of 0.74% while CRWD is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.